Eli Lilly and Company (LLY) Projected to Post Earnings on Thursday
Eli Lilly and Company (NYSE:LLY – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings ...
ETF Daily News9d
Eli Lilly and Company (NYSE:LLY) Trading 0.1% Higher After Analyst Upgrade
Eli Lilly and Company (NYSE ... Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes ...
Mena FN7d
Diabetes Clinical Trial Revolution 200+ Companies Driving Breakthrough Therapies To Reshape Treatment
LY-3209590: Eli Lilly and Company Insulin efsitora alfa ... THDB0206: Tonghua Dongbao Pharmaceutical BC Lispro (THDB0206) is an ultra-rapid-acting insulin analog developed by Tonghua Dongbao ...
pharmaphorum3d
Why the drug pricing debate is focused on insulin
The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.